Cargando…
Attenuation of fibrosis in vitro and in vivo with SPARC siRNA
INTRODUCTION: SPARC is a matricellular protein, which, along with other extracellular matrix components including collagens, is commonly over-expressed in fibrotic diseases. The purpose of this study was to examine whether inhibition of SPARC can regulate collagen expression in vitro and in vivo, an...
Autores principales: | Wang, Jiu-Cun, Lai, Syeling, Guo, Xinjian, Zhang, Xuefeng, de Crombrugghe, Benoit, Sonnylal, Sonali, Arnett, Frank C, Zhou, Xiaodong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888211/ https://www.ncbi.nlm.nih.gov/pubmed/20359365 http://dx.doi.org/10.1186/ar2973 |
Ejemplares similares
-
Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017) -
siRNAs targeted to Smad4 prevent renal fibrosis in vivo
por: Morishita, Yoshiyuki, et al.
Publicado: (2014) -
Positive-charge tuned gelatin hydrogel-siSPARC injectable for siRNA anti-scarring therapy in post glaucoma filtration surgery
por: Chun, Yong Yao, et al.
Publicado: (2021) -
The Function of SPARC as a Mediator of Fibrosis
por: Trombetta-eSilva, Jessica, et al.
Publicado: (2012) -
Targeted delivery of ZNF416 siRNA-loaded liposomes attenuates experimental pulmonary fibrosis
por: Cheng, Demin, et al.
Publicado: (2022)